Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nucleic acid immunotherapeutics and vaccines: A promising approach to glioblastoma multiforme treatment
Lauren Dain, Guizhi Zhu
International Journal of Pharmaceutics (2023) Vol. 638, pp. 122924-122924
Closed Access | Times Cited: 13

Showing 13 citing articles:

Vaccine-based immunotherapy and related preclinical models for glioma
Binghao Zhao, Longping Yao, Maryam Hatami, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 10, pp. 965-981
Open Access | Times Cited: 8
Molecular mechanisms of tumour development in glioblastoma: an emerging role for the circadian clock
Nina Nelson, Angela Relógio
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 6
Characterization of prevalent tyrosine kinase inhibitors and their challenges in glioblastoma treatment
Mahdie Rahban, Sara Joushi, Hamideh Bashiri, et al.
Frontiers in Chemistry (2024) Vol. 11
Open Access | Times Cited: 4
The transformative potential of mRNA vaccines for glioblastoma and human cancer: technological advances and translation to clinical trials
Iulia Tapescu, Peter J. Madsen, Pedro R. Löwenstein, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
The Complexity of Malignant Glioma Treatment
Linde F. C. Kampers, Dennis S. Metselaar, Maria Vinci, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 879-879
Open Access
Recent Advances in mRNA-Based Therapeutics for Neurodegenerative Diseases and Brain Tumors
Lizhi Yang, Shuo Li, Chao Hou, et al.
Nanoscale (2024)
Closed Access | Times Cited: 3
Advancing Cancer Immunotherapy: The Potential of mRNA Vaccines As a Promising Therapeutic Approach
Falak Goyal, Anandini Chattopadhyay, Umashanker Navik, et al.
Advanced Therapeutics (2023) Vol. 7, Iss. 2
Open Access | Times Cited: 8
Fabrication of pH-responsive temozolomide (TMZ)-clacked tannic acid-altered zeolite imidazole nanoframeworks (ZIF-8) enhance anticancer activity and apoptosis induction in glioma cancer cells
Chongwen Ren, Qingqing Tu, Jinchao He
Journal of Biomaterials Science Polymer Edition (2024) Vol. 35, Iss. 13, pp. 1978-1998
Closed Access | Times Cited: 2
Recent advances in development and delivery of non-viral nucleic acid therapeutics for brain tumor therapy
Donat Kögel, Achim Temme, Achim Aigner
Pharmacology & Therapeutics (2024) Vol. 266, pp. 108762-108762
Open Access | Times Cited: 1
Nanomedicine strategies for central nervous system (CNS) diseases
Shreya Nagri, Olivia Rice, Yupeng Chen
Frontiers in Biomaterials Science (2023) Vol. 2
Open Access | Times Cited: 3
The potential of mRNA vaccine in HCC treatment
Rui Han
International Journal of Immunotherapy and Cancer Research (2023) Vol. 9, Iss. 1, pp. 008-012
Open Access | Times Cited: 2
Multi-targeted Tyrosine Kinase Inhibitors in the Treatment of Cancer and Neurodegenerative Disorders

Frontiers research topics (2024)
Closed Access
mRNA Vaccines in Glioma: Antigen Selection, Immune Profiling, Comprehensive Strategies and Challenges
Fan Yang
Transactions on Materials Biotechnology and Life Sciences (2024) Vol. 7, pp. 270-278
Closed Access
Page 1

Scroll to top